Category: Health Services, Science & Nature, Technology

Tags: Olverembatinib in India, Targeted Medicine, Precision Medicine, Advanced Therapeutics, Hematology, Innovative Treatment, Named Patient Program

Olverembatinib is an oral targeted medicine developed for adult patients requiring specialized treatment based on specific genetic and clinical characteristics. Available in 30 mg and 40 mg tablet strengths, it is administered according to the prescribed treatment regimen, with dosage and duration determined by the treating healthcare professional based on individual patient requirements and response to therapy.